GLP-1 receptor agonists and CV risk: what do GPs need to know?
This 1-hour RACGP accredited activity aims to enable GPs to confidently select patients with T2D who might benefit from initiation of a GLP-1 receptor agonist as first injectable therapy.
Sign up for free and continue reading
Med CPD offers the widest range of courses and content, all accessible in one place. Click on the Sign up button and start looking after the health of your career.
MDBriefCase Group Inc.
Speakers
Anita Sharma
Peter Purnell
Tom Dover
Duration
1 H
RACGP - Royal Australian College of General Practitioners
Other courses
Become a Med CPD member for free, and the rest comes easy.
Quality Education From
![Meaningful Ageing Australia](https://medcpd.com.au/wp-content/uploads/2023/01/Meaningful-Ageing-Australia.png)
![Digital Health Festival](https://medcpd.com.au/wp-content/uploads/2023/01/Digital-Health-Festival.png)
![Avant](https://medcpd.com.au/wp-content/uploads/2023/01/Avant.png)
![Standout Medical Careers](https://medcpd.com.au/wp-content/uploads/2023/01/Standout-Medical-Careers.png)
![Immunisation Coalition](https://medcpd.com.au/wp-content/uploads/2023/01/Immunisation-Coalition.png)
![Meaningful Ageing Australia](https://medcpd.com.au/wp-content/uploads/2023/01/Meaningful-Ageing-Australia.png)
![Digital Health Festival](https://medcpd.com.au/wp-content/uploads/2023/01/Digital-Health-Festival.png)
![Avant](https://medcpd.com.au/wp-content/uploads/2023/01/Avant.png)
![Standout Medical Careers](https://medcpd.com.au/wp-content/uploads/2023/01/Standout-Medical-Careers.png)
![Immunisation Coalition](https://medcpd.com.au/wp-content/uploads/2023/01/Immunisation-Coalition.png)